investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Identification and annotation of 3' UTR ends using RNA-seq data
Inanc Birol
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Aly Karsan
BC Cancer Agency
Vancouver, Canada
Inanc Birol
BC Cancer Agency
Vancouver, Canada
Related projects
Yun-Xing Wang
SAXS Core
All cancers but non-melanoma skin cancer
Alan Mak
The tumor suppressors, p53 and PTEN, are also suppressors of vascular smooth muscle cell migration and invasion.
All cancers but non-melanoma skin cancer
Scott Brown
Interrogating large-scale cancer genome datasets to aid in the development of personalized cancer immunotherapies.
All cancers but non-melanoma skin cancer
Dennis Klinman
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
All cancers but non-melanoma skin cancer
Sriram Subramaniam
Technology Development for 3D Electron Microscopy
All cancers but non-melanoma skin cancer
David Hammond
Evaluating the Impact of Mandatory Nutrition Information on Menus
All cancers but non-melanoma skin cancer
Pediatric oncology or childhood cancer
Daniel Durocher
CRC Tier 1 - DNA damage
All cancers but non-melanoma skin cancer
James McMahon
Molecular Targets Laboratory
All cancers but non-melanoma skin cancer
Joseph Barchi
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
All cancers but non-melanoma skin cancer